Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2025-12-24 @ 9:26 PM
NCT ID:
NCT03601832
Eligibility Criteria:
Inclusion Criteria:
* history of sustained monomorphic VT or termination of monomorphic VT by ICD (appropriate therapy) during previous 6 months prior to enrollment
* implantation ICD
* inducibility at least one of monomorphic ventricular tachycardia by ICD during EP study with programmed ventricular stimulation
* history of myocardial infarction (MI)
* left ventricular scar and decreased systolic function of the left ventricle (ejection fraction of left ventricle less than 40%) based on transthoracic ultrasound
* stable chronic heart failure (NYHA II-III)
* older than 18 years
* signed an IRB approved written informed consent document.
* failed at least one invasive catheter ablation procedure or have a contraindication to a catheter ablation procedure
Exclusion Criteria:
* acute myocardial infarction
* chronic heart failure NYHA IV
* channelopathy
* reversible cause of VT (e.g. ionic dysbalance, intoxications)
* pregnancy or breastfeeding
* history of chest radiotherapy
* arrhythmic substrate larger than 100 ccm
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03601832
Study Brief:
Protocol Section:
NCT03601832